GenesisX represents the company’s most accessible robotic system to date. It requires no room shielding or structural anchoring, for example, and the size has been significantly reduced.
The new agreement indicates Siemens will supply NYU Langone Health with its latest gamut of advanced diagnostic imaging offerings across its network of over 300 outpatient and hospital locations.
Sahil Parikh, MD, said it was clear at TCT 2025 that the specialty is getting more and more involved with endovascular procedures for stroke, pulmonary embolism and peripheral artery disease.
Researchers tracked data from nearly 8,000 patients evaluated with Heartflow's FDA-cleared Plaque Analysis software. Overall, the technology's Plaque Staging feature was found to provide significant value during the diagnosis and management of these patients.
The new drug from Merck was linked to several benefits for patients who are already on statins. If an oral PCSK9 inhibitor gains FDA approval, it could be a game-changer for the field of preventive medicine.
The patient reported chest pain multiple times and had a family history of heart disease. According to the lawsuit, however, he was never referred to a cardiologist.
Researchers with two academic health systems recently tried a new approach to increase LDCT uptake, reaching patients electronically outside of a regular appointment and asking them to request a screening.
GenesisX represents the company’s most accessible robotic system to date. It requires no room shielding or structural anchoring, for example, and the size has been significantly reduced.
The new agreement indicates Siemens will supply NYU Langone Health with its latest gamut of advanced diagnostic imaging offerings across its network of over 300 outpatient and hospital locations.
